NVIDIA (NASDAQ:NVDA – Free Report) had its price target hoisted by Truist Financial from $1,177.00 to $1,288.00 in a research report sent to investors on Thursday, MarketBeat Ratings reports. The firm currently has a buy rating on the computer hardware maker’s stock. Several other brokerages have also weighed in on NVDA. Needham & Company LLC […]
NVIDIA (NASDAQ:NVDA – Free Report) had its price target boosted by Needham & Company LLC from $850.00 to $1,200.00 in a research report released on Thursday morning, Marketbeat.com reports. Needham & Company LLC currently has a buy rating on the computer hardware maker’s stock. NVDA has been the subject of several other reports. Piper Sandler […]
NVIDIA (NASDAQ:NVDA – Free Report) had its price objective increased by Wolfe Research from $1,200.00 to $1,250.00 in a research note released on Thursday morning, MarketBeat reports. They currently have an outperform rating on the computer hardware maker’s stock. A number of other research firms have also issued reports on NVDA. Stifel Nicolaus upped their […]
Advisory Services Network LLC lessened its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 24.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 81,793 shares of the pharmacy operator’s stock after selling 26,455 shares during the quarter. Advisory Services […]
Primecap Management Co. CA boosted its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 0.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 3,443,795 shares of the pharmacy operator’s stock after buying an additional 16,650 shares during the period. Primecap Management Co. […]